bluebird bio and Lonza take the opening plenary stage at the CAR-TCR Summit to tell the story of their 10-year journey bringing two gene therapies to market.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center